Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CBRG Stock Forecast 2026-2027
$3.33
Current Price
$0
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to CBRG Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
CBRG Price Momentum
-37.1%
1 Week Change
-54.3%
1 Month Change
-69.8%
1 Year Change
-69.8%
Year-to-Date Change
-80.6%
From 52W High of $17.15
+13.8%
From 52W Low of $2.93
📊 TOP ANALYST CALLS
Did CBRG Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Chain Bridge I is one of their latest high-conviction picks.
Latest CBRG Stock Price Targets & Analyst Predictions
CBRG has shown a year-to-date change of -69.8% and a 1-year change of -69.8%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for CBRG. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CBRG Analyst Ratings
0
Buy
0
Hold
0
Sell
CBRG Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $3.33
Latest CBRG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CBRG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Chain Bridge I (CBRG) Competitors
The following stocks are similar to Chain Bridge I based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Chain Bridge I (CBRG) Financial Data
Valuation Metrics
Market Cap
$0
Enterprise Value
$0
P/E Ratio
N/A
PEG Ratio
N/A
Price/Sales
N/A
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
EPS Growth
N/A
Financial Health
Cash/Price Ratio
N/A
Current Ratio
N/A
Debt/Equity
N/A
ROE
N/A
ROA
N/A
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Chain Bridge I (CBRG) Business Model
About Chain Bridge I
What They Do
Provides 200% daily leveraged exposure to securities.
Business Model
The fund generates returns by investing at least 80% of its net assets in the underlying security and related financial instruments. By achieving 200% daily leveraged exposure, it aims to amplify the price movements of its investments, allowing for potentially higher returns on a daily basis.
Additional Information
The fund operates as a non-diversified entity, which may increase risk but also offers the potential for greater returns depending on market conditions.
Company Information
Sector
Financial Services
Industry
Shell Companies
Employees
0
CEO
Mr. Andrew Cohen
Country
United States
IPO Year
2022
Website
chainbg.comChain Bridge I (CBRG) Latest News & Analysis
Latest News
Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential
1 year ago
Quick Summary
Phytanix Bio, a preclinical stage pharmaceutical company focused on cannabinoid therapeutics, has released a new investor deck as of July 30, 2024.
Why It Matters
Phytanix Bio's investor deck release signals potential growth and investment opportunities in the cannabinoid therapeutics market, attracting interest from investors looking for innovative biotech prospects.
Source: MCAP MediaWire
Market Sentiment:
Neutral
Quick Summary
Chain Bridge I is set to acquire Phytanix Bio, forming a new public company dedicated to developing next-generation cannabinoid and cannabinoid-like medicines.
Why It Matters
The acquisition signals growth potential in the cannabinoid sector, possibly attracting investors seeking innovative biotech opportunities and influencing market valuations.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About CBRG Stock
What is Chain Bridge I's (CBRG) stock forecast for 2027?
Analyst forecasts for Chain Bridge I (CBRG) are not currently available. The stock is trading at $3.33.
Is CBRG stock a good investment in 2027?
Analyst ratings for CBRG are not currently available. The stock is currently trading at $3.33. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CBRG stock?
Price predictions from Wall Street analysts for CBRG are not currently available. The stock is trading at $3.33.
What is Chain Bridge I's business model?
The fund generates returns by investing at least 80% of its net assets in the underlying security and related financial instruments. By achieving 200% daily leveraged exposure, it aims to amplify the price movements of its investments, allowing for potentially higher returns on a daily basis.
What is the highest forecasted price for CBRG Chain Bridge I?
Price targets from Wall Street analysts for CBRG are not currently available. The stock is trading at $3.33.
What is the lowest forecasted price for CBRG Chain Bridge I?
Price targets from Wall Street analysts for CBRG are not currently available. The stock is trading at $3.33.
What is the overall CBRG consensus from analysts for Chain Bridge I?
Analyst ratings for CBRG are not currently available. The stock is trading at $3.33.
How accurate are CBRG stock price projections?
Stock price projections, including those for Chain Bridge I, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 2:14 AM UTC